
CyBio AG
FRA:CQJ ISIN:DE0005412308
CyBio AG (ETR:CQJ) is a Germany-based company, providing the development, manufacture and marketing of laboratory systems and equipment, as well as related software. The Company offers systems for the preparation, transport of specified substances, as well as systems for the detection of pharmaceutical and biotechnological agents in those substances. Its core products are simultaneous pipetting and imaging technologies. The Company operates through four subsidiaries, including CLS Laborautomationssysteme GmbH i. L. Reutlingen (in liquidation), CyBio US Inc, CyBio Northern Europe Ltd and CyBio Japan Co, Ltd. Its customers are pharmaceutical and biotechnological companies in the European Union and the United States, as well as academic research institutes.

News
CyBio AG / Contract / Ad hoc: CLS Laborautomationssysteme GmbH concludes Asset Deal with Manz Automation Tübingen GmbH Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
###
718 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 7) (Since Published: 718)